Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

Purpose

Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Robert Davis

Chairman and CEO, Merck

Find out more


Alignment with Guiding Principles

We believe it is vital to state clearly to the world the set of our beliefs about Inclusive Capitalism. As such, we start with our Statement of Guiding Principles for Inclusive Capitalism. Knowing that words alone are not enough, each of us is making a series of commitments about how we will operate our institutions so that they help achieve Inclusive Capitalism. These commitments are forward-looking statements based on current goals, expectations and assumptions, which are not guarantees of future performance. For more information, please refer to our Terms of Use

Filter by commitments

View all
People icon People
Planet icon Planet
Principles of Governance icon Principles of Governance
Prosperity icon Prosperity

Summary

Our global water strategy aims to achieve sustainable water management within our operations and our supply chain. By 2025, we will maintain global water use at or below 2015 levels.

Activities & Initiatives

To achieve these strategic objectives, we are focusing on the following commitments:

• Ensuring that our wastewater discharges comply with local and national standards, as well as internal requirements

• Understanding and controlling our operational water footprint

• Managing water risk at our facilities and in our supply chain

• Reporting publicly on our water use and goals

Measures & Targets

By 2025, will maintain global water use at or below 2015 levels. Progress as of 12/31/23: 16% reduction in water use as compared to 2015 baseline

SDG Focus Area(s):

Summary

In 2024, we committed to a net-zero target for our greenhouse gas (GHG) emissions across our global operations (Scopes 1, 2, and 3) by 2045, aligned with the guidelines of the Science Based Targets Initiative (SBTi).

Activities & Initiatives

Our previous climate commitment was to be carbon neutral for Scopes 1&2 by 2025.

We have now increased our ambition and better aligned our approach with established guidelines by committing to be net zero by 2045 across Scopes 1, 2 & 3, aligned with the SBTi criteria. Our near-term reduction targets (2030) have been approved by SBTi. In addition, we have continued to find ways to decrease our energy demand and increase the amount of renewable energy we purchase. In our Business Partner Code of Conduct, we request that suppliers conserve energy and engage in activities aimed at reducing GHG emissions. Our Procurement team engages our strategic suppliers in our efforts to reduce the environmental impacts within our supply chain.

Measures & Targets

Progress as of 12/31/23: In progress.

SDG Focus Area(s):

Summary

Reduce company's value chain (scope 3) GHG emissions by 30% by 2030, from a 2019 baseline.

Activities & Initiatives

Our analysis shows that our Scope 3 GHG emissions impacts are more than seven times greater than our combined Scopes 1&2 emissions. We are working to reduce those impacts through a robust supplier engagement approach to drive collaboration upstream and downstream from our value chain. By engaging with our suppliers in a phased approach, we can identify key ways to reduce our GHG emissions and pinpoint additional tangible benefits for the business.

In 2023, we have actively worked with suppliers representing 50 percent of our Scope 3 emissions footprint. We aim to expand this number to 80 percent in 2024. Additionally, we are striving to reduce waste in our operations, to use more sustainable materials, and to change the way we commute and travel for business to further embed environmental sustainability into the way we work.

Measures & Targets

Reduce value chain (Scope 3) GHG emissions by 30% by 2030, from a 2019 baseline. Progress: 4% increase in Scope 3 emissions from 2019 baseline as of 12/31/23

SDG Focus Area(s):

Summary

By 2025, at least 50% of our sites will send zero waste to landfills.

Activities & Initiatives

The amount of waste we generate reflects the efficiency of our manufacturing processes. Operational waste is primarily generated from the following activities:

• Manufacturing

• Packaging

• On-site wastewater treatment

• Research

Waste minimization begins with the evaluation of our product designs and manufacturing processes. Through our Green & Sustainable Science program (see GRI 301 on page 84), we design processes that use safer chemicals, consume less energy, use less water and other resources, and generate less waste. Our process development biologists, chemists and engineers have the expertise to create more sustainable ways to make our products. We continuously strive to reduce the amount of operational waste we generate and to maximize the use of environmentally beneficial disposal methods such as recycling, composting and waste-to-energy. To ensure our waste is managed in an environmentally responsible manner, we use only approved waste disposal facilities. Approved facilities demonstrate that they have the systems, technologies and practices to manage our waste streams responsibly and in compliance with all applicable requirements. We routinely audit these facilities to verify the acceptability of their systems and practices. (2022/2023 Impact Report pg. 107) Waste minimization begins with the upfront evaluation of our product designs and manufacturing processes. Through our Green and Sustainable Science program, we design processes that use safer chemicals, consume less energy, use less water and other resources, and generate less waste. Our process development biologists, chemists and engineers have the expertise to create more sustainable ways to make our products. We continuously strive to reduce the amount of operational waste we generate and to maximize the use of environmentally beneficial disposal methods such as recycling, composting and waste-to-energy. To ensure our waste is managed in an environmentally responsible manner, we use only approved waste disposal facilities. Approved facilities demonstrate that they have the systems, technologies and practices to manage our waste streams responsibly and in compliance with all applicable requirements. We routinely audit these facilities to verify the acceptability of their systems and practices. (2022/2023 Impact Report p. 111; pg. 107)

Measures & Targets

By 2025, at least 50% of sites will send zero waste to landfills. Progress: In 2023, 55% of sites sent zero waste to landfill.

SDG Focus Area(s):

Summary

By 2025, no more than 20% of our global operational waste will be sent to landfills and incinerators (without energy recovery).

Activities & Initiatives

The amount of waste we generate reflects the efficiency of our manufacturing processes. Operational waste is primarily generated from the following activities:

• Manufacturing

• Packaging

• On-site wastewater treatment

• Research

Waste minimization begins with the evaluation of our product designs and manufacturing processes. Through our Green & Sustainable Science program (see GRI 301 on page 84), we design processes that use safer chemicals, consume less energy, use less water and other resources, and generate less waste. Our process development biologists, chemists and engineers have the 

expertise to create more sustainable ways to make our products. We continuously strive to reduce the amount of operational waste we generate and to maximize the use of environmentally beneficial disposal methods such as recycling, composting and waste-to-energy. To ensure our waste is managed in an environmentally responsible manner, we use only approved waste disposal facilities. Approved facilities demonstrate that they have the systems, technologies and practices to manage our waste streams responsibly and in compliance with all applicable requirements. We routinely audit these facilities to verify the acceptability of their systems and practices. (2022/2023 Impact Report pg. 107) Waste minimization begins with the upfront evaluation of our product designs and manufacturing processes. Through our Green and Sustainable Science program, we design processes that use safer chemicals, consume less energy, use less water and other resources, and generate less waste. Our process development biologists, chemists and engineers have the expertise to create more sustainable ways to make our products. We continuously strive to reduce the amount of operational waste we generate and to maximize the use of environmentally beneficial disposal methods such as recycling, composting and waste-to-energy. To ensure our waste is managed in an environmentally responsible manner, we use only approved waste disposal facilities. Approved facilities demonstrate that they have the systems, technologies and practices to manage our waste streams responsibly and in compliance with all applicable requirements. We routinely audit these facilities to verify the acceptability of their systems and practices. (2022/2023 Impact Report p. 111; pg. 107)

Measures & Targets

By 2025, no more than 20% of our global operational waste will be sent to landfills and incinerators without energy recovery). In 2023, 15% of operational waste was sent to landfill and incinerators (without energy recovery).

SDG Focus Area(s):

Summary

Further advance health equity by reaching more than 50 million people in LMICs and populations underserved by health care in high-income countries with our social investments, by 2025.

Activities & Initiatives

In 2023, we provided $44 million in social investments to address health equity through philanthropy, strategic collaborations and impact investing. Our investments help advance health equity around the world by addressing the barriers that many individuals face in seeking and receiving high-quality health care.

Our 2023 investments reached more than 21 million people in LMICs and underserved populations in high-income countries. That brings our three-year total (2021-2023) of people reached to more than 54 million, exceeding our goal to reach more than 50 million people by 2025. We also track health care workers trained through the initiatives we support. In 2023, our partners trained an estimated 349,000 workers - extending our impact for years to come. Our social investments are guided and reviewed by expert advisory bodies, including an internal Impact Investing Council; an internal Economic Inclusion, Workforce Development and Health Equity Council; and external advisory committees for the MECTIZAN Donation Program and Merck for Mothers.

Measures & Targets

Progress: 21.2 million people reached from 12/31/22 to 12/31/23. Total number of people reached to date: 54.8 million.

SDG Focus Area(s):

Summary

Enable 350 million people to access our innovative medicines and vaccines through access solutions by 2025.

Activities & Initiatives

Grounded in a deliberate systematic approach, our Company develops, tests and implements market-based solutions that address barriers to access and affordability of our medicines and vaccines. This allows us to serve the greatest number of patients today, while meeting the needs of patients in the future. Where appropriate, we pursue these solutions in partnership with private enterprises, government agencies, multilateral and non-governmental organizations. When market-based solutions are inadequate or unavailable, we pursue programs to provide direct access to our medicines and vaccines, including product donations and patient assistance programs.

Measures & Targets

Progress: Enabled access for 240 million people from 12/31/22 to 12/31/23.

SDG Focus Area(s):

Summary

Reach at least 75% of countries around the world annually with our products.

Activities & Initiatives

Our approach to commercialization, manufacturing, and supply chain planning focuses on extending access to our products, driving innovation through digital tools, and demonstrating value to our stakeholders. We are using a collaborative enterprise go-to-market model to allow earlier planning for all markets, including high-, middle- and low-income countries. The aim is to enable access to our medicines and vaccines globally, including the areas of the world where they are needed most. Our supply chain operations are integrated across the enterprise, playing a crucial role along product lifecycles. We design supply chains comprised of internal sites and external partners that enable resiliency while improving access in a sustainable way. Our Digital Logistics Program helps build the supply chain of the future and ensure continuous supply of critical medicines and vaccines to patients worldwide through efficient, tech-enabled operations. The cloud-based data integration service gives insights into the physical flow of our products, minimizing disruptions and improving service and security while reducing costs.

Measures & Targets

Reach at least 75% of countries around the world annually with our products. Progress: 79% of countries were reached in 2023.

SDG Focus Area(s):

Summary

Reduce our operational greenhouse gas (GHG) emissions (Scope 1&2) 46% by 2030, from a 2019 baseline.

Activities & Initiatives

From 2022 to 2023, our combined year-over-year Scope 1 and market-based Scope 2 GHG emissions reduced by four percent. The decrease was primarily due to reductions in market-based Scope 2 GHG emissions. Market-based Scope 2 GHG emissions reduced due to an increase in usage of renewable electricity.

Measures & Targets

Reduce our operational greenhouse gas (GHG) emissions (Scope 1&2) 46% by 2030, from a 2019 baseline. Progress: 12% reduction in Scope 1 and 2 emissions from 2019 baseline as of 12/31/23.

SDG Focus Area(s):

Summary

Source 100% of our purchased electricity from renewables by 2025.

Activities & Initiatives

We have committed to sourcing 100 percent of our purchased electricity from renewable energy by 2025. Photovoltaic (PV) arrays, wind turbines and other renewable energy installations avoid emissions, helping to reduce energy demand peaks and postpone or preclude adding new power plants. We continually look for opportunities for new on-site installations, vendor-supplied renewable energy through the electrical grid, and virtual power purchase agreement (VPPA) and power purchase agreement (PPA) projects.

In April 2023, our second VPPA, and our first in Europe, Cabrerizas Wind, began its operation.

We have an offtake agreement with EDP Renewables for 40 megawatts (MW).

Since 2019, our continued efforts at renewable energy procurement have resulted in a total of 213.5 MW of VPPA and PPA commitments.

This includes two more VPPA contracts that we anticipate starting operations for in 2024/2025—a 58 MW Old 300 Solar project in Texas and a 51 MW Postigo Solar project in Spain. The regional breakdown of these commitments is as follows: 

• North America: 118 MW

• Europe: 91 MW

 • Asia Pacific: 5 MW

Measures & Targets

Source 100% of our purchased elecricity from renewables by 2025. Progress: 57% of purchased elecricity sourced from renewables in 2023

SDG Focus Area(s):

Summary

Maintain 100% compliance to privacy and data protection regulatory requirements for active incident monitoring, risk/harm analysis and on-time notification of data breaches.

Activities & Initiatives

Information about our Company, products and people is one of our most valuable assets. We are committed to the ethical use, management, and protection of information. Our commitment applies not only to our Company’s information but also to the information entrusted to us by others. Our tools, processes and procedures ensure we appropriately collect, use and safeguard this data throughout its lifecycle to preserve its integrity and to prevent unauthorized access or disclosure. In addition, we continue to improve upon our comprehensive, global, state-of-the-art information security and cyber resiliency program.

Measures & Targets

Maintain 100% compliance to privacy and data protection regulatory requirements for active incident monitoring, risk/harm analysis and on-time notification of data breaches. Progress: 100% compliance maintained in 2021, 2022, and 2023.

Join

Sign up your company

Recognizing it will take alignment of all our organizations to scale impact globally, we invite you to join the movement as a Steward of Inclusive Capitalism. Together, the collective action of Council members will contribute to a fairer, more inclusive and sustainable future for all people and our planet.